BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 6976773)

  • 1. Immunological adverse effects of anticonvulsants. What is their clinical relevance?
    De Ponti F; Lecchini S; Cosentino M; Castelletti CM; Malesci A; Frigo GM
    Drug Saf; 1993 Mar; 8(3):235-50. PubMed ID: 8452664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoblastic lymphadenopathy, systemic lupus erythematosus, and related disorders. Possible pathogenetic pathways.
    Gleichmann E; van Elven F; Gleichmann H
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):708-23. PubMed ID: 40433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic problems in hydantoin immunopathy. Review of the literature and description of 3 cases].
    Amadori G; Fiore D
    Minerva Med; 1984 Nov; 75(42):2503-19. PubMed ID: 6392934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
    Matzner Y; Polliack A
    Isr J Med Sci; 1978 Aug; 14(8):865-9. PubMed ID: 700999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angioimmunoblastic lymphadenopathy].
    Hunderi OH
    Tidsskr Nor Laegeforen; 1980 Nov; 100(32):1907-9. PubMed ID: 7456049
    [No Abstract]   [Full Text] [Related]  

  • 6. Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin.
    Tsung SH; Lin JI
    Ann Clin Lab Sci; 1981; 11(6):542-5. PubMed ID: 6976773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
    Kojima M; Motoori T; Asano S; Nakamura S
    Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angioimmunoblastic lymphadenopathy (author's transl)].
    Rupniewska ZM
    Przegl Lek; 1980; 37(5):481-3. PubMed ID: 6999550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angioimmunoblastic lymphadenopathy with dysproteinemia].
    Marchi L; Frascisco M; Mairano D; Biarese V; Andrione P; Manachino D; Lovisetto P
    Recenti Prog Med; 1989 Jun; 80(6):326-32. PubMed ID: 2672196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioimmunoblastic lymphadenopathy.
    Su WP
    Dermatol Clin; 1985 Oct; 3(4):759-68. PubMed ID: 3916179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of immunoblastic lymphadenopathy].
    Kojima M; Mori N
    Nihon Rinsho; 1983 Nov; 41(11):2629-41. PubMed ID: 6368905
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.